Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Suzhou Raymon Pharmaceuticals Company, Ltd.
Collaborators
NCT07244276 · Primary Pterygium
NCT05456425 · Pterygium
NCT07458126 · Recurrent Pterygium, Conjunctival Scarring
NCT06734663 · Pterygium of Conjunctiva and Cornea, Pterygium of Both Eyes, and more
NCT06042296 · Pterygium
Global Research Management
Glendale, California
United Medical Research Institute
Inglewood, California
Eye Research Foundation Inc
Newport Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions